While both Novera Retatrutide and Durolane address knee discomfort , their methods of effect are significantly contrasting. Novo Nordisk's Retatrutide check here is a dual agonist targeting glucagon-like peptide-1 and the GIP receptor, primarily used for body control , which potentially secondarily